Experimental Breast Cancer Drug Floods Tumors with a “Surge” of Toxic Lipids
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer ...
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer ...
In a groundbreaking study, researchers, led by Yu et al., have ventured into the realms of computational biology and medicinal ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine